新产业收盘下跌2.29%，滚动市盈率23.17倍，总市值426.25亿元

Group 1 - The core viewpoint of the articles highlights the performance and market position of Shenzhen New Industry Biomedical Engineering Co., Ltd. in the medical device sector, particularly in the in vitro diagnostics field [1][2] - As of August 1, the company's stock closed at 54.25 yuan, down 2.29%, with a rolling PE ratio of 23.17 times and a total market capitalization of 42.625 billion yuan [1] - The average PE ratio for the medical device industry is 53.65 times, with a median of 37.22 times, placing the company at the 50th position within the industry [1][2] Group 2 - The company reported a net profit of 438 million yuan for Q1 2025, reflecting a year-on-year increase of 2.65%, with a sales gross margin of 68.01% [1] - The company has received notable accolades, including the "National Brand Gold Award" for medical equipment in 2024, indicating strong customer satisfaction and service recognition, particularly in tertiary hospitals [1] - As of March 31, 2025, the number of shareholders increased to 19,269, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1]